跳至主要内容
临床试验/NCT03194243
NCT03194243Unknown不适用

Pathway and Urgent caRe of Dyspneic Patient at the Emergency Department in LorrainE District

Central Hospital, Nancy, France9 个研究点 分布在 1 个国家目标入组 75,000 人开始时间: 2017年10月5日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
75,000
试验地点
9
主要终点
All cause mortality

研究概览

简要总结

This is an observational prospective multicenter study of patients admitted for acute dyspnea in an emergency department of the participating centers in the Lorraine district.

The primary objective is to assess the outcome of this population according to the cause of acute dyspnea as well as identify the predictors of this outcome, both overall and according to each acute dyspnea cause.

详细描述

This observational prospective multicenter study will be conducted using data from electronic medical records, acquired as part of usual care, in patients admitted for acute dyspnea in the emergency department. Clinical, treatment, laboratory and imaging data acquired during the hospitalization (in the emergency department and in the department that admitted the patients following the emergency department stay) will be collected.

Vital status will be recorded at 30 days and 1 year post-admission.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men or women > or = 18 years.
  • Patients with acute dyspnea admitted for acute dyspnea in the emergency department.
  • Patient informed.

排除标准

  • Cardiorespiratory arrest.
  • Patient having expressed his or her opposition.

结局指标

主要结局

All cause mortality

时间窗: From emergency admission for acute dyspnea up until 1 year

次要结局

  • Initial diagnosis in the emergency department(At admission)
  • Demographic data(through hospital stay, an average of 10 days)
  • Treatment data(through hospital stay, an average of 10 days)
  • Laboratory data(through hospital stay, an average of 10 days)
  • Clinical data(through hospital stay, an average of 10 days)
  • Brain Natriuretic Peptide(Through hospital stay, an average of 10 days)
  • Estimated glomerular function rate(Through hospital stay, an average of 10 days)
  • Estimated plasma volume(Through hospital stay, an average of 10 days)
  • Use of diuretics(Through hospital stay, an average of 10 days)
  • Time of use of diuretics(Through hospital stay, an average of 10 days)
  • Liver biological biomarkers(Through hospital stay, an average of 10 days)
  • Time of use of non-invasive ventilation(Through hospital stay, an average of 10 days)
  • Time of use of nitrates(Through hospital stay, an average of 10 days)
  • Imaging data(through hospital stay, an average of 10 days)
  • Use of non-invasive ventilation(Through hospital stay, an average of 10 days)
  • Duration of hospitalization(At final discharge, an average of 10 days after admission)
  • Final diagnosis of the initial hospitalization stay(At final discharge, an average of 10 days after admission)
  • Urea(Through hospital stay, an average of 10 days)
  • Use of nitrates(Through hospital stay, an average of 10 days)
  • Department type admitting the patient following emergency management(Through hospital stay, an average of 10 days)
  • All cause in-hospital mortality(At final discharge, an average of 10 days after admission)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验